Nucleic Acid Amplification Testing Market Size to Hit USD 20.62 Billion by 2032, Driven by Precision Diagnostics and Infectious Disease Surveillance
According to SNS Insider, Nucleic Acid Amplification Testing Market Growth is Fueled by Technological Advancements and Expanding Clinical Applications.
Austin, April 11, 2025 (GLOBE NEWSWIRE) -- According to a new report by SNS Insider, the Nucleic Acid Amplification Testing (NAAT) Market, valued at USD 7.36 billion in 2023, is projected to reach USD 20.62 billion by 2032, growing at a compound annual growth rate (CAGR) of 12.16% over the forecast period from 2024 to 2032. This significant growth is attributed to technological advancements in diagnostic techniques and an increasing emphasis on the early detection of diseases.
The U.S. Nucleic Acid Amplification Testing Market, valued at USD 2.17 billion in 2023, is projected to reach USD 5.77 billion by 2032, growing at a compound annual growth rate (CAGR) of 11.48% over the forecast period from 2024 to 2032.Get a Sample Report of Nucleic Acid Amplification Testing Market@ https://www.snsinsider.com/sample-request/5823
Market Overview
The NAAT market in the United States has grown significantly over the years due to a robust healthcare infrastructure, and an emphasis on early detection of diseases has been increased in the country. Advanced diagnostic technologies have further advanced the market because of the ever-increasing rate of infectious diseases and the urgency for accurate solutions for diagnosis.
The NAAT market is experiencing strong growth because of the rising incidence of infectious diseases like influenza, hepatitis, and sexually transmitted diseases. The need for precise and speedy diagnostic techniques has caused a universal adaptation of NAAT technologies. In addition, continued technological evolution, especially in Polymerase Chain Reaction (PCR) methodologies, has improved the precision and effectiveness of these tests and made them a key factor in driving market growth.
Major Players Analysis Listed in this Report are:
F. Hoffmann-La Roche Ltd
Becton, Dickinson and Company
Danaher Corporation
Abbott Laboratories
Illumina, Inc.
Siemens Healthineers AG
bioMérieux SA
Novartis AG
Bio-Rad Laboratories, Inc.
Seegene Inc.
QIAGEN N.V.
Nucleic Acid Amplification Testing Market Report Scope
Report Attributes
Details
Market Size in 2023
US$ 7.36 billion
Market Size by 2032
US$ 20.62 billion
CAGR
CAGR of 12.16% From 2024 to 2032
Base Year
2023
Forecast Period
2024-2032
Historical Data
2020-2022
Key Regional Coverage
North America (US, Canada, Mexico), Europe (Eastern Europe [Poland, Romania, Hungary, Turkey, Rest of Eastern Europe] Western Europe] Germany, France, UK, Italy, Spain, Netherlands, Switzerland, Austria, Rest of Western Europe]), Asia Pacific (China, India, Japan, South Korea, Vietnam, Singapore, Australia, Rest of Asia Pacific), Middle East & Africa (Middle East [UAE, Egypt, Saudi Arabia, Qatar, Rest of Middle East]), Africa [Nigeria, South Africa, Rest of Africa], Latin America (Brazil, Argentina, Colombia Rest of Latin America)
Segment Analysis
By Type
In 2023, Polymerase Chain Reaction (PCR) tests became the most prominent segment in the NAAT market, with a significant revenue share. The reason for the dominance of PCR tests lies in their high specificity, sensitivity, and capacity to identify a wide variety of pathogens. Moreover, the ongoing advancements in PCR technology, such as the invention of real-time PCR and digital PCR, have widened its clinical diagnostic applications, further establishing its market dominance.
Isothermal Nucleic Acid Amplification Technology (INAAT) tests are expected to be the most rapidly growing segment over the forecast period. Advances like loop-mediated isothermal amplification (LAMP) have made the process of amplification easier, allowing for rapid and affordable diagnostics. The fact that INAAT tests can work at constant temperatures without the requirement of advanced equipment makes them highly appropriate for point-of-care applications, leading to their growth and adoption.
By Application
Infectious disease testing accounted for the highest revenue share in 2023 due to the worldwide prevalence of infectious diseases and the urgent need for timely and precise diagnostics. The COVID-19 pandemic further highlighted the significance of NAAT in controlling infectious outbreaks, resulting in higher usage of these tests.
Oncology testing is also expected to grow at the highest rate during the forecast period. The advent of advances in molecular diagnostics has made it easier to detect genetic mutations and biomarkers related to different types of cancers. The increasing focus on personalized medicine and the early detection of cancer is driving demand for NAAT in oncology applications.
By End-Use
Central and reference labs led the market for NAAT in 2023 with a large revenue share. These labs are well-equipped with modern infrastructure and experienced professionals, which enables them to conduct high-throughput testing with accuracy. The centralization of such facilities facilitates the effective processing of bulk samples, leading to market leadership.
Point-of-care settings are anticipated to experience the fastest growth over the forecast period. The trend towards decentralized healthcare and the demand for quick diagnostics have prompted the invention of portable NAAT devices. These devices allow for instant decision-making and are capable of enhancing patient outcomes, especially in resource-constrained settings.
Need Any Customization Research on Nucleic Acid Amplification Testing Market, Enquire Now@ https://www.snsinsider.com/enquiry/5823
Nucleic Acid Amplification Testing Market Segmentation
By Type
Polymerase Chain Reaction (PCR) Tests
Isothermal Nucleic Acid Amplification Technology (INAAT) Tests
Ligase Chain Reaction (LCR) Tests
By Application
Infectious Disease Testing
COVID-19 Testing
Mosquito-Borne Disease Testing
Influenza Testing
Sexually Transmitted Infections Testing
Hepatitis Testing
Tuberculosis Testing
Others
Oncology Testing
Genetic & Mitochondrial Disease Testing
Others
By End-use
Hospitals
Central And Reference Laboratories
Others
Regional Analysis
In 2023, North America dominated the NAAT market with the largest revenue share, fueled by sophisticated healthcare infrastructure, high levels of adoption of cutting-edge diagnostic technologies, and a strong emphasis on the detection of diseases in the early stages. The location of major market players and continuous research and development activities also contribute to the position of the region.
The Asia-Pacific market is expected to have the highest growth over the forecast period. The growth is driven by a large and heterogeneous patient pool, growing healthcare spending, and increasing awareness of early disease diagnosis. Moreover, government efforts towards enhancing healthcare access and the development of local manufacturing units are expected to drive the adoption of NAAT in the region.
Recent Developments
In March 2023, BD (Becton, Dickinson, and Company) received FDA 510(k) clearance for the BD Vaginal Panel on the BD COR System, a high-throughput molecular diagnostic test for large laboratories. This test enables the direct detection of the three most common infectious causes of vaginitis, enhancing diagnostic accuracy and efficiency.Buy a Single-User PDF of Nucleic Acid Amplification Testing Market Analysis & Outlook Report 2024-2032@ https://www.snsinsider.com/checkout/5823
Table of Contents – Major Key Points
1. Introduction
2. Executive Summary
3. Research Methodology
4. Market Dynamics Impact Analysis
5. Statistical Insights and Trends Reporting
6. Competitive Landscape
7. Nucleic Acid Amplification Testing Market by Type
8. Nucleic Acid Amplification Testing Market by Application
9. Nucleic Acid Amplification Testing Market by End-use
10. Regional Analysis
11. Company Profiles
12. Use Cases and Best Practices
13. Conclusion
Access Complete Report Details of Nucleic Acid Amplification Testing Market Analysis & Outlook 2024-2032@ https://www.snsinsider.com/reports/nucleic-acid-amplification-testing-market-5823
[For more information or need any customization research mail us at info@snsinsider.com]
About Us:
SNS Insider is one of the leading market research and consulting agencies that dominates the market research industry globally. Our company's aim is to give clients the knowledge they require in order to function in changing circumstances. In order to give you current, accurate market data, consumer insights, and opinions so that you can make decisions with confidence, we employ a variety of techniques, including surveys, video talks, and focus groups around the world.
CONTACT: Contact Us: Jagney Dave - Vice President of Client Engagement Phone: +1-315 636 4242 (US) | +44- 20 3290 5010 (UK)
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Hypebeast
an hour ago
- Hypebeast
ASICS Unveils GEL-KAYANO 12.1 "Black/Silver" Hybrid
Name:ASICS GEL-KAYANO 12.1 'Black/Silver'Colorway:'Black/Silver'SKU:1203A759.001Retail Price:$160 USDRelease Date:2025Where to Buy:ASICS Notes:ASICSis set to release theGEL-KAYANO 12.1'Black/Silver' in 2025, blending heritage design with modern performance. Priced at $160 USD, the new silhouette merges the upper of theGEL-KAYANO 12with the outsole of theGEL-NIMBUS 17, offering a lightweight mesh build and the brand's iconic tiger stripes. This hybrid model aims to deliver both comfort and stability in a sleek, monochrome package. Notable details include Japanese branding on the tongue and blacked-out 'ASICS' logos on the heels.
Yahoo
an hour ago
- Yahoo
Critical One Makes Strategic Uranium Asset Divestment
TORONTO, June 12, 2025 (GLOBE NEWSWIRE) -- Critical One Energy Inc. (formerly Madison Metals Inc.) ('Critical One' or the 'Company') (CSE: CRTL) (OTCQB: MMTLF) (FSE: 4EF0) is pleased to announce that Dark Star Minerals Inc. ('Dark Star') (CSE: BATT) (FSE: P0W), a well-managed, uranium-focused, publicly-listed company, has entered into an acquisition agreement with Critical One to acquire 100% of its interests in the Khan and Cobra Uranium Projects, located in Namibia's highly prospective Erongo uranium province. 'Divesting the Company's uranium assets and focusing on the Howells Lake Antimony-Gold Project ('Howells Lake Project') enhances our shareholder value by strategically refining the Company's critical metals and minerals mission,' said Duane Parnham, Executive Chairman and CEO of Critical One. 'I believe this shift in our critical metals strategy aligns with global market trends driven by the energy transition, and will offer higher growth potential and improved returns. Howell Lake's antimony deposits allow us to capitalize on the rapidly growing demand for these critical metals. Plus, the project provides gold exploration upside in a period when the yellow metal's value is reaching all-time market highs.' Parnham added, 'By forming this alliance with Dark Star, our investment in uranium continues to have great potential. This divestiture allows Critical One to focus on its capital allocation on high-margin, high-demand critical minerals, thereby optimizing our portfolio for long-term profitability, reducing exposure to market risks, and strengthening our competitive position in a future-focused industry, ultimately driving sustainable value creation for shareholders.' Under the terms of the letters of intent agreement ('LOI'), Dark Star has the opportunity to acquire all of Critical One's interest in the Khan and Cobra Uranium Projects through staged cash payments and issuances of common shares to the Company over a two-year period. No fairness opinion or independent valuation of the uranium assets was sought by Critical One or Dark Star for this agreement. A summary of terms for the LOI is provided below, concurrently issued in the Dark Star news release dated June 12, 2025. Payment Date Cash Payment Amount Securities Issuance On the date of execution of this LOI (the 'LOI Execution Date') US$10,000 - Upon the later of: (a) the date that is five days of the LOI Execution Date; and (b) receipt of Exchange approval for the LOI - 200,000 common shares (each, a 'Share') of Dark Star Upon the execution of the Definitive Agreement (the 'Definitive Agreement Execution Date') US$150,000 14,000,000 Dark Star Shares On or before the date that is four (4) months from the Definitive Agreement Execution Date US$100,000 - On or before first anniversary of the Definitive Agreement Execution Date US$250,000 US$1,000,000 in Dark Star Shares On or before second anniversary of the Definitive Agreement Execution Date US$250,000 US$750,000 in Dark Star Shares Total: US$760,000 Once the staged cash and share issuances reach a combined value above US$3.5 million (as outlined in the table), Critical One will be granted a 2% gross overriding royalty on all metals produced from the two uranium projects. Upon signing of the LOI, Critical One received US$10,000 in cash and was issued 200,000 common shares of Dark Star, priced at CDN$0.075 at close of business on June 11, 2025. This will be followed by subsequent cash and common share payments in accordance with a definitive agreement to be signed within 60 days. The definitive agreement will be subject to the approval of the usual regulatory approvals. About Critical One Energy Inc. Critical One Energy Inc. (formerly Madison Metals Inc.) is a forward-focused critical minerals and upstream energy company, powering the future of clean energy and advanced technologies. The addition of the Howells Lake Antimony-Gold Project broadens the Company's exposure to antimony, one of the most in-demand critical minerals. Backed by seasoned management expertise and prime resource assets, Critical One is strategically positioned to meet the rising global demand for critical minerals and metals. Its mine exploration portfolio is led by antimony-gold exploration potential in Canada and uranium investment interests in Namibia, Africa. By leveraging its technical, managerial, and financial expertise, the Company upgrades and creates high-value projects, thereby driving growth and delivering value to its shareholders. Additional information about Critical One Energy Inc. can be found at and on the Company's SEDAR+ profile at For further information, please contact: Duane ParnhamExecutive Chairman & CEOCritical One Energy Inc. +1 (416) 489-0092ir@ Media inquiries: Adam BelloManager, Media & Analyst RelationsPrimoris Group Inc.+1 (416) 489-0092media@ Neither the Canadian Securities Exchange nor CIRO accepts responsibility for the adequacy or accuracy of this release. Forward-looking Statements This news release contains 'forward-looking information' within the meaning of applicable securities laws. All statements contained herein that are not clearly historical in nature may constitute forward-looking information. In some cases, forward-looking information can be identified by words or phrases such as 'may', 'will', 'expect', 'likely', 'should', 'would', 'plan', 'anticipate', 'intend', 'potential', 'proposed', 'estimate', 'believe' or the negative of these terms, or other similar words, expressions, and grammatical variations thereof, or statements that certain events or conditions 'may' or 'will' happen, or by discussions of strategy. Forward-looking information contained in this press release includes, but is not limited to, statements relating to the terms and timing of the private placement described in this press release and the anticipated uses of the proceeds raised from such private placement. Where the Company expresses or implies an expectation or belief as to future events or results, such expectation or belief is based on assumptions made in good faith and believed to have a reasonable basis. Such assumptions include, without limitation, that: the Company will receive all necessary approval required in order to complete the issuance of the securities pursuant to the private placement described in in this press release; and that there will be sufficient interest from potential investors in order to complete the private placement on the terms as described herein or at all. However, forward-looking statements are subject to risks, uncertainties, and other factors, which could cause actual results to differ materially from future results expressed, projected, or implied by such forward-looking statements. Such risks include, but are not limited to, the risk that the Company will not be able to proceed with the issuance of units on the terms described in this press release or at all. Accordingly, undue reliance should not be placed on forward-looking statements and the forward-looking statements contained in this press release are expressly qualified in their entirety by this cautionary statement. The forward-looking statements contained herein are made as at the date hereof and are based on the beliefs, estimates, expectations, and opinions of management on such date. The Company does not undertake any obligation to update publicly or revise any such forward-looking statements or any forward-looking statements contained in any other documents whether as a result of new information, future events or otherwise or to explain any material difference between subsequent actual events and such forward-looking information, except as required under applicable securities law. Readers are cautioned to consider these and other factors, uncertainties, and potential events carefully and not to put undue reliance on forward-looking in to access your portfolio
Yahoo
an hour ago
- Yahoo
Nuveen Australian Real Estate Debt Strategy Reaches A$650 Million with CPP Investments Commitment
SYDNEY, June 12, 2025 /CNW/ - Nuveen, one of the largest asset managers globally with over US$1.3 trillion AUM*, has reached second close of its commingled Australian commercial real estate debt strategy with commitments of over A$650 million. Canada Pension Plan Investment Board (CPP Investments), through its subsidiary CPPIB Credit Investments Inc., invested A$300 million, joining Teachers Insurance and Annuity Association of America (TIAA) and Temasek as strategic partners of Nuveen for this strategy. Total AUM are expected to exceed A$1 billion including capital approved for co-investments. The strategy is already more than 40% deployed via committed loan investments focusing on institutional senior and junior loans secured by prime real estate in Australia. Preferred sectors for the strategy are industrial / logistics and residential, with a selective approach to retail, office and alternatives across major cities in Australia. The strategy leverages both Nuveen Real Estate's global debt platform, which currently has over 55 dedicated specialists, and the team of more than 60 at Nuveen Real Estate in Asia. The strategy is led by Dugald Marr, Nuveen's Head of Debt Australia and New Zealand, and the support of an experienced team with a long track record of originating and structuring high-quality loan investments in this market. Investments are also aligned to Nuveen Real Estate's comprehensive responsible investment processes and ESG factor analysis. This includes waste reduction and energy consumption, climate risk analysis and social aspects with the ability to structure Green Loans or Sustainable Linked Loans where applicable to incentivise ESG targets on behalf of clients. The investment comes at a time when Australian commercial real estate debt offers the potential for a compelling blend of stability, attractive yields, and strong collateral protection, all of which are increasingly important to investors concerned about global volatility. Australia's mature market, supported by robust economic foundations, strict regulatory requirements for banks and the need for more alternative capital sources provides a good foundation for long-term investment in this space. The strategy will continue to focus on repeat institutional borrowers, conservative lending parameters and prime assets in sectors that benefit most from Australia's high population growth and limited supply. Andrew Kleinig, Head of Australia and the Global Client Group for South East Asia at Nuveen, said: "This is another milestone for the strategy. With CPP Investments' commitment, we will continue our focus on strategic, in-depth partnerships with the highest calibre of investors. We are excited to work with a like-minded partner who also shares a high conviction on the asset class. CPP Investments has provided significant value-add as a strategic investor, ensuring long-term success and growth of the partnership. It showcases Nuveen's pedigree in real estate investment and our ability to bring regionally tailored solutions across both equity and debt platforms. We believe Nuveen's offering across real assets more broadly is well-positioned to help clients across Asia navigate volatility alongside managing their responsible investment goals." Raymond Chan, Managing Director & Head of APAC Credit at CPP Investments, said: "Australia is one of our key markets in Asia Pacific and this transaction marks an important milestone for our credit strategy in the region. The investment builds upon our extensive market research and insights from our successful investments in Australia. Leveraging Nuveen's strong local network and capabilities, this partnership enables us to tap into attractive real estate debt investments in Australia and further augment our credit program in the region. These opportunities offer stability and attractive yields amid global volatility, contributing to long-term returns for the CPP Fund." *Top 20 largest global asset manager based on Pensions & Investments, 12 Jun 2023. Rankings based on total worldwide assets as of 31 Dec 2022 reported by each responding asset manager, with 434 firms responding; updated annually. TIAA is the parent company of Nuveen. About NuveenNuveen, the investment manager of TIAA, offers a comprehensive range of outcome-focused investment solutions designed to secure the long-term financial goals of institutional and individual investors. Nuveen has $1.3 trillion in assets under management as of 30 September 2024 and operations in 27 countries. Its investment specialists offer deep expertise across a comprehensive range of traditional and alternative investments through a wide array of vehicles and customized strategies. For more information, please visit Nuveen Real Estate is one of the largest investment managers in the world with US$142 billion of assets under management. Managing a suite of funds and mandates, across both public and private investments, and spanning both debt and equity across diverse geographies and investment styles, we provide access to every aspect of real estate investing. With over 90 years of real estate investing experience and more than 770 employees* located across 30+ cities throughout the United States, Europe and Asia Pacific, the platform offers global reach with deep sector expertise, providing investors access to high quality investments across the private real estate investment landscape. For further information, please visit us at *Includes 360+ real estate investment professionals, supported by a further 411 Nuveen Nuveen, 31 March 2025. About CPP InvestmentsCanada Pension Plan Investment Board (CPP Investments™) is a professional investment management organization that manages the Fund in the best interest of the more than 22 million contributors and beneficiaries of the Canada Pension Plan. In order to build diversified portfolios of assets, investments are made around the world in public equities, private equities, real estate, infrastructure and fixed income. Headquartered in Toronto, with offices in Hong Kong, London, Mumbai, New York City, San Francisco, São Paulo and Sydney, CPP Investments is governed and managed independently of the Canada Pension Plan and at arm's length from governments. At March 31, 2025, the Fund totalled C$714.4 billion. For more information, please visit or follow us on LinkedIn, Instagram or on X @CPPInvestments. SOURCE Canada Pension Plan Investment Board View original content to download multimedia: Sign in to access your portfolio
